Drug recall · October 22, 2014
TOPIRAMATE Tablets 200 mg recall
Why: Presence of Foreign Tablets: Presence of topiramate 100 mg tablets comingled with 200 mg tablets.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
TOPIRAMATE Tablets 200 mg, 60 Tablet Bottles, Rx Only. Manufactured by Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ USA 08534. NDC 68382-141-14.
- Lots / codes
Lot #: MN9828, Expiry: Oct 2015.
- Quantity
- 14,568 Bottles
- Company
- Zydus Pharmaceuticals USA Inc, Pennington, NJ
- Distribution
- U.S. Nationwide
- Initiated
- September 15, 2014 · Voluntary: Firm initiated
- Classified
- October 10, 2014
- Reported
- October 22, 2014
- Ended
- September 20, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Topiramate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.